Similar articles

• The pathobiologic implications for treatment. Old and new strategies in the treatment of chronic asthma.

  Horiuchi T, Castro M. Horiuchi T, et al. Clin Chest Med. 2000 Jun;21(2):381-95, x. doi: 10.1016/s0272-5231(05)70273-2. Clin Chest Med. 2000. PMID: 10907595 Review.
• Salmeterol versus sodium cromoglycate for the protection of exercise induced asthma in children--a randomised cross-over study.

  Zimmermann T, Gulyas A, Bauer CP, Steinkamp G, Trautmann M. Zimmermann T, et al. Eur J Med Res. 2003 Sep 29;8(9):428-34. Eur J Med Res. 2003. PMID: 14555299 Clinical Trial.
• Long-acting beta-agonists, tachyphylaxis, and corticosteroids.

  Sears MR. Sears MR. Chest. 1996 Apr;109(4):862-4. doi: 10.1378/chest.109.4.862. Chest. 1996. PMID: 8635359 No abstract available.
• Oral montelukast versus inhaled salmeterol to prevent exercise-induced bonchonconstriction.

  Brestel EP. Brestel EP. Ann Intern Med. 2000 Sep 5;133(5):392; author reply 392-3. doi: 10.7326/0003-4819-133-5-200009050-00020. Ann Intern Med. 2000. PMID: 10979887 No abstract available.
• Salmeterol in the management of paediatric asthma.

  Jones K. Jones K. Respir Med. 1994 Oct;88(9):639-43. doi: 10.1016/s0954-6111(05)80059-9. Respir Med. 1994. PMID: 7809435 Review. No abstract available.